255 related articles for article (PubMed ID: 8201378)
1. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.
Loehrer PJ; Kim K; Aisner SC; Livingston R; Einhorn LH; Johnson D; Blum R
J Clin Oncol; 1994 Jun; 12(6):1164-8. PubMed ID: 8201378
[TBL] [Abstract][Full Text] [Related]
2. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
[TBL] [Abstract][Full Text] [Related]
3. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial.
Loehrer PJ; Chen M; Kim K; Aisner SC; Einhorn LH; Livingston R; Johnson D
J Clin Oncol; 1997 Sep; 15(9):3093-9. PubMed ID: 9294472
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy for advanced thymoma. Preliminary results of an intergroup study.
Loehrer PJ; Perez CA; Roth LM; Greco A; Livingston RB; Einhorn LH
Ann Intern Med; 1990 Oct; 113(7):520-4. PubMed ID: 2203292
[TBL] [Abstract][Full Text] [Related]
5. Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience.
Berruti A; Borasio P; Gerbino A; Gorzegno G; Moschini T; Tampellini M; Ardissone F; Brizzi MP; Dolcetti A; Dogliotti L
Br J Cancer; 1999 Nov; 81(5):841-5. PubMed ID: 10555755
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of invasive thymoma. A retrospective study of 22 cases.
Göldel N; Böning L; Fredrik A; Hölzel D; Hartenstein R; Wilmanns W
Cancer; 1989 Apr; 63(8):1493-500. PubMed ID: 2466548
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy of invasive thymoma.
Fornasiero A; Daniele O; Ghiotto C; Sartori F; Rea F; Piazza M; Fiore-Donati L; Morandi P; Aversa SM; Paccagnella A
J Clin Oncol; 1990 Aug; 8(8):1419-23. PubMed ID: 2380761
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.
Kim ES; Putnam JB; Komaki R; Walsh GL; Ro JY; Shin HJ; Truong M; Moon H; Swisher SG; Fossella FV; Khuri FR; Hong WK; Shin DM
Lung Cancer; 2004 Jun; 44(3):369-79. PubMed ID: 15140551
[TBL] [Abstract][Full Text] [Related]
9. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
Loehrer PJ; Jiroutek M; Aisner S; Aisner J; Green M; Thomas CR; Livingston R; Johnson DH
Cancer; 2001 Jun; 91(11):2010-5. PubMed ID: 11391579
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for invasive thymoma. A 13-year experience.
Fornasiero A; Daniele O; Ghiotto C; Piazza M; Fiore-Donati L; Calabró F; Rea F; Fiorentino MV
Cancer; 1991 Jul; 68(1):30-3. PubMed ID: 2049749
[TBL] [Abstract][Full Text] [Related]
11. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience.
Grassin F; Paleiron N; André M; Caliandro R; Bretel JJ; Terrier P; Margery J; Le Chevalier T; Ruffié P
J Thorac Oncol; 2010 Jun; 5(6):893-7. PubMed ID: 20521356
[TBL] [Abstract][Full Text] [Related]
12. Chemotherapy of invasive or metastatic thymoma: report of 11 cases.
Fornasiero A; Daniele O; Sperandio P; Morandi P; Fosser VP; Cartei G; Fiorentino MV
Cancer Treat Rep; 1984 Oct; 68(10):1205-10. PubMed ID: 6543151
[TBL] [Abstract][Full Text] [Related]
13. Randomized phase III trial of standard timed doxorubicin plus cisplatin versus circadian timed doxorubicin plus cisplatin in stage III and IV or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
Gallion HH; Brunetto VL; Cibull M; Lentz SS; Reid G; Soper JT; Burger RA; Andersen W;
J Clin Oncol; 2003 Oct; 21(20):3808-13. PubMed ID: 14551299
[TBL] [Abstract][Full Text] [Related]
14. Retreatment of recurrent invasive thymoma with platinum, doxorubicin, and cyclophosphamide.
Lara PN; Bonomi PD; Faber LP
Chest; 1996 Oct; 110(4):1115-7. PubMed ID: 8874280
[TBL] [Abstract][Full Text] [Related]
15. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
[TBL] [Abstract][Full Text] [Related]
16. Thymoma. A retrospective study of 87 cases.
Park HS; Shin DM; Lee JS; Komaki R; Pollack A; Putnam JB; Cox JD; Hong WK
Cancer; 1994 May; 73(10):2491-8. PubMed ID: 8174044
[TBL] [Abstract][Full Text] [Related]
17. Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy.
Zucali PA; De Pas T; Palmieri G; Favaretto A; Chella A; Tiseo M; Caruso M; Simonelli M; Perrino M; De Vincenzo F; Toffalorio F; Damiano V; Pasello G; Garbella E; Ali M; Conforti F; Ottaviano M; Cioffi A; De Placido S; Giordano L; Bertossi M; Destro A; Di Tommaso L; Santoro A
J Clin Oncol; 2018 Feb; 36(4):342-349. PubMed ID: 29240542
[TBL] [Abstract][Full Text] [Related]
18. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
[TBL] [Abstract][Full Text] [Related]
19. EST 2582 phase II trial of cisplatin in metastatic or recurrent thymoma.
Bonomi PD; Finkelstein D; Aisner S; Ettinger D
Am J Clin Oncol; 1993 Aug; 16(4):342-5. PubMed ID: 8328413
[TBL] [Abstract][Full Text] [Related]
20. Refractory recurrent thymoma successfully treated with long-acting somatostatin analogue and prednisolone.
Ito J; Sekiya M; Miura K; Yoshimi K; Suzuki T; Seyama K; Izumi H; Uekusa T; Takahashi K
Intern Med; 2009; 48(12):1061-4. PubMed ID: 19525599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]